Key result
Preoperative nonselective α-blockade was associated with a significantly lower time-weighted average of systolic blood pressure >160 mm Hg (median difference -0.391 mm Hg) compared to selective α-blockade during surgery for pheochromocytomas and paragangliomas.
Why the study?
Both selective and nonselective α-blockade are used for preoperative preparation in patients with pheochromocytomas and paragangliomas, but their effects on perioperative outcomes remain inconclusive.
Does preoperative nonselective α-blockade reduce intraoperative hypertension in patients undergoing surgery for pheochromocytomas and paragangliomas compared to selective α-blockade?
Cohort (n=286)
No
Does preoperative nonselective α-blockade reduce intraoperative hypertension in patients undergoing surgery for pheochromocytomas and paragangliomas compared to selective α-blockade?
Mean Difference: -0.391 (95% CI -0.828–-0.032)
Absolute Event Rate: 0.472% vs 1.114%
p-value: p=0.016
Preoperative nonselective α-blockade is associated with significantly less intraoperative hypertension compared to selective α-blockade in patients undergoing surgery for pheochromocytomas and paragangliomas.
Supports considering nonselective α-blockade to limit intraoperative hypertension; leaves open superiority pending randomized trials.
BACKGROUND: Both selective and nonselective α-blockade are used for preoperative preparation in patients with pheochromocytomas and paragangliomas (PPGLs). However, the effects of different types of α-blockade on perioperative outcomes remain inconclusive. This study was designed to assess the association between the choice of α-blockade and the amount of intraoperative hypertension in patients undergoing surgery for PPGLs. METHODS: In this propensity-matched retrospective cohort study, data of patients who received either selective or nonselective α-blockade preoperatively and underwent surgery for PPGLs were collected. The primary end point was the time-weighted average above the systolic blood pressure (SBP) of 160 mm Hg (TWA-SBP >160 mm Hg), which was calculated as the total area of the SBP-time curve above the SBP of 160 mm Hg and divided by anesthesia duration. RESULTS: A total of 286 patients were included in analysis; of them, 156 received selective α-blockade and 130 nonselective α-blockade. After propensity score matching, 89 patients remained in each group. Patients who received nonselective α-blockade had a lower TWA-SBP >160 (median 0.472 mm Hg, interquartile range [IQR], 0.081-1.300) versus those who received selective α-blockade (median 1.114 mm Hg, IQR, 0.162-2.853; median difference -0.391, 95% confidence interval [CI], -0.828 to -0.032; P = .016); they also had a lower highest SBP during surgery (193 ± 24 mm Hg versus 205 ± 34 mm Hg; mean difference -12, 95% CI, -20 to -3; P = .008). Postoperative outcomes did not differ significantly between the 2 groups. CONCLUSIONS: For patients undergoing surgery for PPGLs, preoperative nonselective α-blockade was associated with less intraoperative hypertension when compared with selective α-blockade.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2020) conducted a cohort in Pheochromocytomas and paragangliomas (n=286). Nonselective α-blockade (phenoxybenzamine) vs. Selective α-blockade (doxazosin, terazosin, or prazosin) was evaluated on Time-weighted average of systolic blood pressure >160 mm Hg (TWA-SBP >160 mm Hg) (MD -0.391, 95% CI -0.828 to -0.032, p=0.016). Preoperative nonselective α-blockade was associated with a significantly lower time-weighted average of systolic blood pressure >160 mm Hg (median difference -0.391 mm Hg) compared to selective α-blockade during surgery for pheochromocytomas and paragangliomas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: